September 2026
M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Lukas Jeker։ Making Genomic Medicine Affordable for More Patients

Lukas Jeker/LinkedIn, Fyodor Urnov/LinkedIn, Sadik Kassim/LinkedIn

Apr 24, 2026, 13:18

Lukas Jeker։ Making Genomic Medicine Affordable for More Patients

Lukas Jeker, Assistant Professor Experimental Transplantation Immunology and Nephrology at University Hospital Basel, shared a post on LinkedIn about a recent article by Fyodor Urnov and Sadik Kassim, published in Nature։

”Very thoughtful words from Fyodor Urnov and Sadik Kassim.

Time and costs to perform safety and efficacy testing are key obstacles that prevent more genome-editing therapies to benefit patients.

Fyodor and Sadik outline 4 key aspects that need to change to move faster, cut costs and scale.

I hope they are correct that costs can be cut dramatically and I hope successful deployment will convince other regulators to adopt similar regulatory frameworks.

Some of the article is US-centric but similar principles can be applied to other legislations.

Some principles will be universal (mainly scientific), others will need local adaptation, and maybe someone can further improve the approach?

Looking forward to what’s to come.

Thanks Fyodor and Sadik (and the many others who are pioneering such treatments) for your energy to bring change.

The last paragraph is particularly strong!

Read it (including the dollar COI disclosure).

I hope there will be a time when we look back and say: yes, there was a time when genomic medicine was unaffordable for most people.

Personalized CRISPR therapies could soon reach thousands – here’s how.”

Title: Personalized CRISPR therapies could soon reach thousands — here’s how

Authors: Fyodor D. Urnov, Sadik H. Kassim

Lukas Jeker։ Making Genomic Medicine Affordable for More Patients